Metformin a biguanide. Its mode of action is thought to be multifactoral and includes delayed uptake of glucose from the intestinal tract, increased peripheral glucose utilisation mediated by increased insulin sensitivity and inhibition of increased

hepatic and renal gluconeogenesis.